Phase I Study New Hep C Drug for Peg/RBV Nonresponders
Peregrine Pharmaceuticals' anti-viral Phase 1 trial is designed to evaluate the safety of escalating doses of Tarvacin in patients with chronic Hepatitis C virus infection.
Below is a summary of the trial parameters:
Tarvacin is a monoclonal antibody designed for solid-tumor cancers.
A Phase I Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Tarvacin™) in Patients Chronically Infected with Hepatitis C Virus (HCV) who are Non-responders or Relapsers after Treatment with Pegylated Interferon plus Ribavirin
Karen Roberts, MS 714.508.6035 ***@****
PHASE I STUDY SITE
Bach & Godofsky, MD, PA, Bradenton, Florida, 34205, United States; Recruiting
Mickey Mays, RNMS, ARNP 941-746-2711 Ext. 39
Eliot W Godofsky, MD, Principal Investigator
Indications: Chronic Hepatitis C virus (HCV) Infection
--Determine safety and tolerability
--Characterize blood pharmacokinetics and viral kinetics
--Define the maximum tolerated dose (MTD) and/or maximum effective dose (MED)
Selected Eligibility Criteria:
--Must be 18 years of age
--Chronic HCV infection based on medical history and detectable serum HCV RNA
--Failure to respond to or relapse after treatment with pegylated interferon plus ribavirin
--No prior exposure to any chimeric antibody
--No decompensated clinical liver disease or cirrhosis or other cause of liver disease such as alcoholic liver disease
--No uncontrolled intercurrent disease
--No requirement for chronic daily treatment with NSAIDs, anti-platelet drugs or steroids
--Must not be pregnant or nursing
--No prior thrombotic or hemorrhagic disorders
thanks for the details, Ben. Someone gave us a preview on an 8/8 thread, I wonder if they got their 30 subjects by now? I think it was mentioned that they were looking for 30 individuals, or did I imagine that one?
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.